Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors
The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.
-
Page/Page column 165
(2009/12/27)
More Articles about upstream products of 959133-22-3
Get Best Price for959133-22-32-[4-(3-fluorobenzyl)-3-(2-hydroxyphenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-methyl-1-(3-trifluoromethyl-phenyl)ethyl]-acetamide